DoD Multiple Sclerosis, Exploration- Hypothesis Development Award | W81XWH 20 MSRP EHDA

Opportunity Information: Apply for W81XWH 20 MSRP EHDA

The DoD Multiple Sclerosis Research Program (MSRP) Exploration - Hypothesis Development Award (Funding Opportunity Number W81XWH 20 MSRP EHDA) is a Department of Defense grant/cooperative agreement opportunity administered through the U.S. Army Medical Research Acquisition Activity (USAMRAA). Its purpose is to back early-stage, idea-driven multiple sclerosis (MS) research that is deliberately high-risk and high-reward, with the expectation that successful projects will open up new directions for the field rather than simply extend what is already known. The core emphasis is on exploring potentially groundbreaking concepts that could reshape how MS is studied, understood, prevented, diagnosed, or treated.

This mechanism is specifically aimed at hypothesis-driven work. Applicants are expected to propose a clear, well-formulated, testable hypothesis and pair it with a strong scientific rationale and a study design that can realistically evaluate the idea. A key feature is that preliminary or published supporting data are not required, which lowers the barrier for genuinely new concepts that may not yet have generated early datasets. In practice, this means the program is making space for investigators to pursue credible but unproven lines of inquiry that might be too speculative for more conventional funding streams, as long as the logic and experimental plan are sound.

Innovation is not just encouraged; it is central to eligibility and competitiveness. The program defines innovative research as work that introduces a novel paradigm, challenges prevailing assumptions, reframes persistent problems from a fresh angle, or otherwise demonstrates a high level of creativity. By contrast, projects that represent incremental progress beyond ongoing research programs or the existing published literature are explicitly described as inconsistent with the intent of the award. The application therefore needs to make a direct, explicit case for why the approach is truly innovative in the MS research landscape, and that burden sits with the Principal Investigator. Reviewers will likely look for a sharp distinction between what is already being done in the field and what this project newly enables or tests.

From an administrative standpoint, the opportunity is listed as discretionary funding under the Science and Technology and other Research and Development category and is associated with CFDA number 12.420. The funding instruments available include both grants and cooperative agreements, indicating that depending on the award, there may be varying levels of government involvement or coordination during project performance. Eligibility is described as unrestricted, meaning it is broadly open to many types of applicant organizations, subject to any additional eligibility clarifications contained in the full announcement. The posting date is April 24, 2020, with an original closing date of October 1, 2020, and the announcement anticipated approximately 10 awards. The public listing shows an award ceiling of 0, which typically signals that the ceiling was not represented in that summary field and would need to be confirmed in the full solicitation documents.

In plain terms, this award is designed for investigators with a bold MS idea that is plausible and testable but not yet backed by extensive preliminary evidence. The best fit is a project that takes a credible scientific leap, outlines a rigorous way to evaluate it, and clearly explains how the work could establish a foundation for follow-on studies and longer-term advances in MS research.

• The Department of Defense, Dept. of the Army -- USAMRAA in the science and technology and other research and development sector is offering a public funding opportunity titled "DoD Multiple Sclerosis, Exploration- Hypothesis Development Award" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 12.420.
• This funding opportunity was created on Apr 24, 2020.
• Applicants must submit their applications by Oct 01, 2020. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• The number of recipients for this funding is limited to 10 candidate(s).
• Eligible applicants include: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled Additional Information on Eligibility.

Apply for W81XWH 20 MSRP EHDA

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: